BusinessNewLink Genetics Shares Its Immuno-Oncology Strategy 2016 Analyst and Investor DayBy Nasdaq OMXOct 25, 2016, 8:08 PM UTC
BusinessVital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With WebcastBy Nasdaq OMXOct 25, 2016, 8:03 PM UTC
BusinessParion Sciences Announces Presentation of Clinical Data with Novel Pulmonary Delivery Device at the 2016 North American Cystic Fibrosis ConferenceBy Nasdaq OMXOct 25, 2016, 12:14 PM UTC
BusinessPortola Pharmaceuticals Submits New Drug Application to U.S. FDA for Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism in Acute Medically Ill PatientsBy Nasdaq OMXOct 25, 2016, 12:04 PM UTC
BusinessMyriad RBM Announces an Agreement with Sanofi to Measure Predictive Cardiovascular Biomarkers in Patients with DiabetesBy Nasdaq OMXOct 25, 2016, 11:05 AM UTC
BusinessOrganovo Announces Release Date for Fiscal Second-Quarter 2017 Financial ResultsBy Nasdaq OMXOct 24, 2016, 12:05 PM UTC
BusinessNewLink Genetics to Host Its Third Quarter 2016 Financial Results Conference Call on November 1, 2016By Nasdaq OMXOct 24, 2016, 11:00 AM UTC
BusinessCytoDyn Files Protocol for Extended Access to PRO 140 for Patients Who Reach the End of PRO 140 Pivotal Phase 3 TrialBy Nasdaq OMXOct 24, 2016, 10:30 AM UTC
